Minimal residual disease assessment in chronic lymphocytic leukaemia
- 作者Hazem A. Sayala; Andy C. Rawstron; Peter Hillmen
- 卷第20卷
- 期第3期
- 文件大小339.48KB
- 发表时间2007
- DOI10.1016/j.beha.2007.03.004
- 页码499-512
Targeting DUBs to degrade oncogenic proteinsCremer, Anjali; Stegmaier, Kimberly · British Journal of Cancer · 2020
Targeting NOTCH1 in Hematopoietic MalignancyRoti, Giovanni; Stegmaier, Kimberly · Critical Reviews™ in Oncogenesis · 2011
New Approaches to Target T-ALLRoti, Giovanni; Stegmaier, Kimberly · Frontiers in Oncology · 2014
The TEL gene and human leukemiaTodd R. Golub; Thomas McLean; Kimberly Stegmaier; Martin Carroll; Michael Tomasson; D. Gary Gilliland · 1996
Scratching the Surface of Immunotherapeutic Targets in NeuroblastomaMalone, Clare F.; Stegmaier, Kimberly · Cancer Cell · 2017
Targeting chromatin complexes in fusion protein-driven malignanciesBrien, Gerard L.; Stegmaier, Kimberly; Armstrong, Scott A. · Nature Reviews Cancer · 2019
Targeted therapy for fusion-driven high-risk acute leukemiaPikman, Yana; Stegmaier, Kimberly · Blood · 2018